يعرض 1 - 10 نتائج من 61 نتيجة بحث عن '"Ciardiello F."', وقت الاستعلام: 0.73s تنقيح النتائج
  1. 1
    دورية أكاديمية
    Cetuximab as third-line rechallenge plus either irinotecan or avelumab is an effective treatment in metastatic colorectal cancer patients with baseline plasma RAS/BRAF wild-type circulating tumor DNA: Individual patient data pooled analysis of CRICKET and CAVE trials

    المؤلفون: Martini, G, Ciardiello, D, Famiglietti, V, Rossini, D, Antoniotti, C, Troiani, T, Napolitano, S, Esposito, L, Latiano, T P, Maiello, E, Del Re, M, Lonardi, S, Aprile, G, Santini, D, Masi, G, Avallone, A, Normanno, N, Pietrantonio, F, Pinto, C, Ciardiello, F, Cremolini, C, Martinelli, E

    المساهمون: Martini, G, Ciardiello, D, Famiglietti, V, Rossini, D, Antoniotti, C, Troiani, T, Napolitano, S, Esposito, L, Latiano, T P, Maiello, E, Del Re, M, Lonardi, S, Aprile, G, Santini, D, Masi, G, Avallone, A, Normanno, N, Pietrantonio, F, Pinto, C, Ciardiello, F, Cremolini, C, Martinelli, E

    مصطلحات موضوعية: cetuximab, immunotherapy, metastatic colorectal cancer, rechallenge

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/36880426; info:eu-repo/semantics/altIdentifier/wos/WOS:000944145900001; volume:12; issue:8; numberofpages:9; journal:CANCER MEDICINE; https://hdl.handle.net/11568/1169589Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85150336357

    الإتاحة: https://doi.org/10.1002/cam4.5699Test
    https://hdl.handle.net/11568/1169589Test

    View record in BASE

    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    Nivolumab in Heavily Pretreated Metastatic Gastric Cancer Patients: Real-Life Data from a Western Population

    المؤلفون: Petrillo A, Tirino G, Zito Marino F, Pompella L, Sabetta R, Panarese I, Pappalardo A, Caterino M, Ventriglia A, Laterza MM, Morgillo F, Orditura M, Ciardiello F, Franco R, De Vita F

    المصدر: OncoTargets and Therapy, Vol Volume 13, Pp 867-876 (2020)

    مصطلحات موضوعية: immune-checkpoint inhibitors, nivolumab, immunotherapy, third line, pd-l1, msi, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

    وصف الملف: electronic resource

    العلاقة: https://www.dovepress.com/nivolumab-in-heavily-pretreated-metastatic-gastric-cancer-patients-rea-peer-reviewed-article-OTTTest; https://doaj.org/toc/1178-6930Test

    الوصول الحر: https://doaj.org/article/e21c61e06e134effab673c8c0810d538Test

    View record in DOAJ النص الكامل

    أضف إلى المفضلة
  3. 3
    دورية أكاديمية
    Skin toxicity as predictor of survival in refractory patients with ras wild‐type metastatic colorectal cancer treated with cetuximab and avelumab (Cave) as rechallenge strategy

    المؤلفون: Ciardiello D., Famiglietti V., Napolitano S., Esposito L., Normanno N., Avallone A., Latiano T., Maiello E., Pietrantonio F., Cremolini C., Santabarbara G., Pinto C., Troiani T., Martinelli E., Ciardiello F., Martini G.

    المساهمون: Ciardiello, D., Famiglietti, V., Napolitano, S., Esposito, L., Normanno, N., Avallone, A., Latiano, T., Maiello, E., Pietrantonio, F., Cremolini, C., Santabarbara, G., Pinto, C., Troiani, T., Martinelli, E., Ciardiello, F., Martini, G.

    مصطلحات موضوعية: Immunotherapy, MCRC, Rechallenge anti‐EGFR, Skin toxicity

    وصف الملف: STAMPA

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/34830870; info:eu-repo/semantics/altIdentifier/wos/WOS:000723622100001; volume:13; issue:22; numberofpages:12; journal:CANCERS; https://hdl.handle.net/11568/1113672Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85118929902; https://www.mdpi.com/2072-6694/13/22/5715Test

    الإتاحة: https://doi.org/10.3390/cancers13225715Test
    https://hdl.handle.net/11568/1113672Test
    https://www.mdpi.com/2072-6694/13/22/5715Test

    View record in BASE

    أضف إلى المفضلة
  4. 4
    دورية أكاديمية
    Real-world clinical outcome and safety of adjuvant therapy in stage III melanoma patients: Data from two Academic Italian Institutions

    المؤلفون: De Falco V., Suarato G., Napolitano R., Argenziano G., Famiglietti V., Amato A., Servetto A., Bianco R., Formisano L., Terrano V., Esposito A., Giugliano M. C., Ciardiello D., Ciardiello F., Napolitano S., Troiani T.

    المساهمون: De Falco, V., Suarato, G., Napolitano, R., Argenziano, G., Famiglietti, V., Amato, A., Servetto, A., Bianco, R., Formisano, L., Terrano, V., Esposito, A., Giugliano, M. C., Ciardiello, D., Ciardiello, F., Napolitano, S., Troiani, T.

    مصطلحات موضوعية: adjuvant therapy, immunotherapy, melanoma, real-world data, targeted therapy

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/36752579; info:eu-repo/semantics/altIdentifier/wos/WOS:000938254200001; journal:INTERNATIONAL JOURNAL OF CANCER; https://hdl.handle.net/11591/491748Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85148608740

    الإتاحة: https://doi.org/10.1002/ijc.34462Test
    https://hdl.handle.net/11591/491748Test

    View record in BASE

    أضف إلى المفضلة
  5. 5
    دورية أكاديمية
    Comparative assessment of early mortality risk upon immune checkpoint inhibitors alone or in combination with other agents across solid malignancies: a systematic review and meta-analysis

    المؤلفون: Viscardi G., Tralongo A. C., Massari F., Lambertini M., Mollica V., Rizzo A., Comito F., Di Liello R., Alfieri S., Imbimbo M., Della Corte C. M., Morgillo F., Simeon V., Lo Russo G., Proto C., Prelaj A., De Toma A., Galli G., Signorelli D., Ciardiello F., Remon J., Chaput N., Besse B., de Braud F., Garassino M. C., Torri V., Cinquini M., Ferrara R.

    المساهمون: Viscardi, G., Tralongo, A. C., Massari, F., Lambertini, M., Mollica, V., Rizzo, A., Comito, F., Di Liello, R., Alfieri, S., Imbimbo, M., Della Corte, C. M., Morgillo, F., Simeon, V., Lo Russo, G., Proto, C., Prelaj, A., De Toma, A., Galli, G., Signorelli, D., Ciardiello, F., Remon, J., Chaput, N., Besse, B., de Braud, F., Garassino, M. C., Torri, V., Cinquini, M., Ferrara, R.

    مصطلحات موضوعية: Breast cancer, Chemotherapy, Early mortality, Gastrointestinal cancer, Genitourinary cancer, Immune checkpoint blocker, Immunotherapy, Lung cancer, Melanoma, Meta-analysis

    العلاقة: info:eu-repo/semantics/altIdentifier/wos/WOS:000907032000002; volume:177; firstpage:175; lastpage:185; numberofpages:11; journal:EUROPEAN JOURNAL OF CANCER; https://hdl.handle.net/11591/483618Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85141288757

    الإتاحة: https://doi.org/10.1016/j.ejca.2022.09.031Test
    https://hdl.handle.net/11591/483618Test

    View record in BASE

    أضف إلى المفضلة
  6. 6
    دورية أكاديمية
    Exploring biological heterogeneity and implications on novel treatment paradigm in BRAF-mutant metastatic colorectal cancer

    المؤلفون: Rodriquenz M. G., Ciardiello D., Latiano T. P., Maiorano B. A., Martinelli E., Silvestris N., Ciardiello F., Maiello E.

    المساهمون: Rodriquenz, M. G., Ciardiello, D., Latiano, T. P., Maiorano, B. A., Martinelli, E., Silvestris, N., Ciardiello, F., Maiello, E.

    مصطلحات موضوعية: BRAF, Colorectal cancer, Immunotherapy, Non-V600E mutation, Secondary resistance, Targeted therapy, Treatment algorithm, V600E mutation, Human, Mutation, Precision Medicine, Proto-Oncogene Proteins B-raf, Colonic Neoplasm, Colorectal Neoplasm, Rectal Neoplasms

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/35337969; info:eu-repo/semantics/altIdentifier/wos/WOS:000795430500002; volume:173; firstpage:103657; journal:CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY; http://hdl.handle.net/11591/469900Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85126917377

    الإتاحة: https://doi.org/10.1016/j.critrevonc.2022.103657Test
    http://hdl.handle.net/11591/469900Test

    View record in BASE

    أضف إلى المفضلة
  7. 7
    دورية أكاديمية
    Immunotherapy in advanced anal cancer: Is the beginning of a new era?

    المؤلفون: Ciardiello D., Pio Guerrera L., Anna Maiorano B., Parente P., Pia Latiano T., Di Maio M., Ciardiello F., Troiani T., Martinelli E., Maiello E.

    المساهمون: Ciardiello, D., Pio Guerrera, L., Anna Maiorano, B., Parente, P., Pia Latiano, T., Di Maio, M., Ciardiello, F., Troiani, T., Martinelli, E., Maiello, E.

    مصطلحات موضوعية: Biomarker, HPV-related tumor, ICI, Immunotherapy, SCCA

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/35279535; info:eu-repo/semantics/altIdentifier/wos/WOS:000831023800005; volume:105; firstpage:102373; journal:CANCER TREATMENT REVIEWS; http://hdl.handle.net/11591/466795Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85125959043

    الإتاحة: https://doi.org/10.1016/j.ctrv.2022.102373Test
    http://hdl.handle.net/11591/466795Test

    View record in BASE

    أضف إلى المفضلة
  8. 8
    دورية أكاديمية
    Immunotherapy for Biliary Tract Cancer in the Era of Precision Medicine: Current Knowledge and Future Perspectives

    المؤلفون: Ciardiello D., Maiorano B. A., Parente P., Rodriquenz M. G., Latiano T. P., Chiarazzo C., Pazienza V., Guerrera L. P., Amoruso B., Normanno N., Martini G., Ciardiello F., Martinelli E., Maiello E.

    المساهمون: Ciardiello, D., Maiorano, B. A., Parente, P., Rodriquenz, M. G., Latiano, T. P., Chiarazzo, C., Pazienza, V., Guerrera, L. P., Amoruso, B., Normanno, N., Martini, G., Ciardiello, F., Martinelli, E., Maiello, E.

    مصطلحات موضوعية: Biliary tract cancer, Immunotherapy, Precision medicine, Target therapy

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/35055006; info:eu-repo/semantics/altIdentifier/wos/WOS:000747067300001; volume:23; issue:2; firstpage:820; journal:INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES; http://hdl.handle.net/11591/462667Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85122826317

    الإتاحة: https://doi.org/10.3390/ijms23020820Test
    http://hdl.handle.net/11591/462667Test

    View record in BASE

    أضف إلى المفضلة
  9. 9
    دورية أكاديمية
    Holistic Approach to Immune Checkpoint Inhibitor-Related Adverse Events

    المؤلفون: Poto R., Troiani T., Criscuolo G., Marone G., Ciardiello F., Tocchetti C. G., Varricchi G.

    المساهمون: Poto, R., Troiani, T., Criscuolo, G., Marone, G., Ciardiello, F., Tocchetti, C. G., Varricchi, G.

    مصطلحات موضوعية: cancer, cytotoxic T lymphocyte-associated protein (CTLA-4), immune checkpoint inhibitor (ICI), immune-related adverse event (irAE), immunotherapy, PD-L1, programmed cell death protein -1 (PD-1), B7-H1 Antigen, Human, Immune Checkpoint Inhibitor, Ligand, Retrospective Studie, Coliti, Pneumonia

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/35432346; info:eu-repo/semantics/altIdentifier/wos/WOS:000783968500001; volume:13; firstpage:804597; journal:FRONTIERS IN IMMUNOLOGY; http://hdl.handle.net/11591/469896Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85128424455

    الإتاحة: https://doi.org/10.3389/fimmu.2022.804597Test
    http://hdl.handle.net/11591/469896Test

    View record in BASE

    أضف إلى المفضلة
  10. 10
    دورية أكاديمية
    Cetuximab as third‐line rechallenge plus either irinotecan or avelumab is an effective treatment in metastatic colorectal cancer patients with baseline plasma RAS/BRAF wild‐type circulating tumor DNA: Individual patient data pooled analysis of CRICKET and CAVE trials

    المؤلفون: Martini, G., Ciardiello, D., Famiglietti, V., Rossini, D., Antoniotti, C., Troiani, T., Napolitano, S., Esposito, L., Latiano, T. P., Maiello, E., Del Re, M., Lonardi, S., Aprile, G., Santini, D., Masi, G., Avallone, A., Normanno, N., Pietrantonio, F., Pinto, C., Ciardiello, F.

    المصدر: Cancer Medicine; Apr2023, Vol. 12 Issue 8, p9392-9400, 9p

    مصطلحات موضوعية: CIRCULATING tumor DNA, COLORECTAL cancer, EPIDERMAL growth factor receptors, CETUXIMAB, METASTASIS

    النص الكامل

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث